Search Results - Aleshcheva, G.

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    High prevalence of cardiotropic viruses in endomyocardial biopsies from patients with inflammatory cardiomyopathy demonstrated by a novel targeted NGS approach

    High prevalence of cardiotropic viruses in endomyocardial biopsies from patients with inflammatory cardiomyopathy demonstrated by a novel targeted NGS approach by Baumeier, C, Harms, D, Altmann, B, Aleshcheva, G, Bock, T, Escher, F, Schultheiss, H P

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The diagnostic value of endomyocardial biopsy in the era of precision medicine: data from over 8,000 patients with comprehensive biopsy diagnostics

    The diagnostic value of endomyocardial biopsy in the era of precision medicine: data from over 8,000 patients with comprehensive biopsy diagnostics by Escher, F, Baumeier, C, Aleshcheva, G, Gross, U, Schultheiss, H P

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Machine learning methods for diagnostic disease prediction and treatment decisions in parvovirus B19 positive viral cardiomyopathy

    Machine learning methods for diagnostic disease prediction and treatment decisions in parvovirus B19 positive viral cardiomyopathy by Baumeier, C, Starlinger, J, Aleshcheva, G, Escher, F, Schultheiss, H P

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Interleukin-17 and interferon-gamma in patients with different forms of non-ischemic cardiomyopathies

    Interleukin-17 and interferon-gamma in patients with different forms of non-ischemic cardiomyopathies by Zach, V, Plappert, C, Aleshcheva, G, Baumeier, C, Alasfar, L, Schultheiss, H P, Escher, F

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Plasminogen activator inhibitor-1 (PAI-1) is anti-fibrogenic in human inflammatory cardiomyopathy

    Plasminogen activator inhibitor-1 (PAI-1) is anti-fibrogenic in human inflammatory cardiomyopathy by Baumeier, C, Escher, F, Pietsch, H, Aleshcheva, G, Schultheiss, H P

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    P6450Plasminogen activator inhibitor type-1 (PAI-1) expression relates to the presence of myocardial inflammation in patients with nonischemic cardiomyopathy

    P6450Plasminogen activator inhibitor type-1 (PAI-1) expression relates to the presence of myocardial inflammation in patients with nonischemic cardiomyopathy by Escher, F, Agirbasli, M, Lassner, D, Aleshcheva, G, Schultheiss, H P

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    P4006Characterization of leucocyte subpopulations in circulating blood of patients with chronic thromboembolic pulmonary hypertension (CTEPH)

    P4006Characterization of leucocyte subpopulations in circulating blood of patients with chronic thromboembolic pulmonary hypertension (CTEPH) by Voss, S., Wiedenroth, C., Essmann, L., Troidl, C., Nef, H., Doerr, O., Lipps, C., Hoffmann, J., Aleshcheva, G., Mayer, E., Hamm, C., Liebetrau, C.

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: